Tafenoquine + chloroquine for malaria, vivax

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Sep 2015: Trial registered, NCT02563496
  2. 6 Feb 2017: Trial started, NCT02563496

The trials

NCT02563496: A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria

State
Completed
Phase
Phase 2
People
60 taking part
Started
6 Feb 2017
Primary completion
15 Dec 2019
Arms
Tafenoquine 50 mg, Tafenoquine 100 mg, Tafenoquine 150 mg, Tafenoquine 200 mg, Tafenoquine 300 mg
Results
Posted on the registry
  1. 30 Sep 2015: Trial registered
  2. 6 Feb 2017: Trial started
  3. 17 Feb 2020: Trial completed
  4. 2 Nov 2020: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.